Plasticity of Lgr5-Negative Cancer Cells Drives Metastasis in Colorectal Cancer.

Lgr5 cancer stem cells circulating tumor cells colorectal cancer intravital microscopy metastasis microenvironment plasticity

Journal

Cell stem cell
ISSN: 1875-9777
Titre abrégé: Cell Stem Cell
Pays: United States
ID NLM: 101311472

Informations de publication

Date de publication:
02 04 2020
Historique:
received: 23 07 2019
revised: 24 12 2019
accepted: 13 02 2020
pubmed: 15 3 2020
medline: 28 4 2021
entrez: 15 3 2020
Statut: ppublish

Résumé

Colorectal cancer stem cells (CSCs) express Lgr5 and display extensive stem cell-like multipotency and self-renewal and are thought to seed metastatic disease. Here, we used a mouse model of colorectal cancer (CRC) and human tumor xenografts to investigate the cell of origin of metastases. We found that most disseminated CRC cells in circulation were Lgr5

Identifiants

pubmed: 32169167
pii: S1934-5909(20)30061-8
doi: 10.1016/j.stem.2020.02.008
pmc: PMC7118369
pii:
doi:

Substances chimiques

Biomarkers, Tumor 0
LGR5 protein, human 0
Receptors, G-Protein-Coupled 0

Types de publication

Journal Article Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

569-578.e7

Commentaires et corrections

Type : CommentIn
Type : CommentIn

Informations de copyright

Copyright © 2020 The Authors. Published by Elsevier Inc. All rights reserved.

Déclaration de conflit d'intérêts

Declaration of Interests The authors declare no competing interests.

Références

Nat Biotechnol. 2017 Jun;35(6):569-576
pubmed: 28459449
Nat Med. 1997 Jul;3(7):730-7
pubmed: 9212098
J Hepatol. 2010 Oct;53(4):677-85
pubmed: 20619916
Cell. 2015 May 7;161(4):933-45
pubmed: 25957691
Int J Oncol. 2018 Aug;53(2):567-578
pubmed: 29901191
Nature. 2011 Jan 20;469(7330):415-8
pubmed: 21113151
Cell Rep. 2018 Feb 6;22(6):1600-1614
pubmed: 29425513
Cell Rep. 2016 Mar 15;14(10):2281-8
pubmed: 26947068
Nat Methods. 2012 Jul;9(7):671-5
pubmed: 22930834
Cell Stem Cell. 2007 Oct 11;1(4):389-402
pubmed: 18371377
Nature. 2013 Sep 19;501(7467):328-37
pubmed: 24048065
Nature. 2012 Aug 23;488(7412):522-6
pubmed: 22854781
Cell. 2008 May 16;133(4):704-15
pubmed: 18485877
Nat Protoc. 2018 Feb;13(2):235-247
pubmed: 29300390
Cell Stem Cell. 2014 Mar 6;14(3):342-56
pubmed: 24607406
EMBO Mol Med. 2017 Jul;9(7):869-879
pubmed: 28468934
Cell. 2011 Mar 4;144(5):646-74
pubmed: 21376230
Nature. 2009 May 14;459(7244):262-5
pubmed: 19329995
Cell. 2010 Oct 1;143(1):134-44
pubmed: 20887898
Nat Cell Biol. 2012 Oct;14(10):1099-1104
pubmed: 23000963
Proc Natl Acad Sci U S A. 2003 Apr 1;100(7):3983-8
pubmed: 12629218
J Histochem Cytochem. 1974 Dec;22(12):1077-83
pubmed: 4374474
Intravital. 2013 Apr 1;2(2):e25294
pubmed: 25013744
Nature. 2007 Jan 4;445(7123):111-5
pubmed: 17122771
Nat Cell Biol. 2013 Apr;15(4):338-44
pubmed: 23548926
Nature. 2014 Mar 20;507(7492):362-365
pubmed: 24531760
Nature. 2017 Mar 29;543(7647):676-680
pubmed: 28358093
Nat Med. 2017 Oct 6;23(10):1124-1134
pubmed: 28985214
Nature. 2018 Feb 22;554(7693):538-543
pubmed: 29443964
Nat Cell Biol. 2010 May;12(5):468-76
pubmed: 20418870
Nat Rev Cancer. 2018 Mar;18(3):187-201
pubmed: 29348578
Annu Rev Pathol. 2016 May 23;11:47-76
pubmed: 27193450
Nat Cell Biol. 2018 Oct;20(10):1193-1202
pubmed: 30177776
Cell Stem Cell. 2016 Jun 2;18(6):827-38
pubmed: 27212702
Nat Protoc. 2013 Mar;8(3):583-94
pubmed: 23429719
Nat Rev Cancer. 2013 Oct;13(10):727-38
pubmed: 24060864
Science. 2012 Aug 10;337(6095):730-5
pubmed: 22855427
Nature. 2015 May 7;521(7550):43-7
pubmed: 25924068
Science. 2013 Jun 7;340(6137):1190-4
pubmed: 23744940
Cell Syst. 2016 Oct 26;3(4):385-394.e3
pubmed: 27693023
Nature. 2012 Aug 23;488(7412):527-30
pubmed: 22854777
Cell Stem Cell. 2015 May 7;16(5):465-76
pubmed: 25957902
Proc Natl Acad Sci U S A. 2017 Mar 21;114(12):E2357-E2364
pubmed: 28270604
Oncotarget. 2015 Jun 10;6(16):14300-17
pubmed: 25973543
Cell. 2019 Jun 13;177(7):1888-1902.e21
pubmed: 31178118
Nature. 2017 May 11;545(7653):187-192
pubmed: 28355176
Cell. 2012 Mar 2;148(5):1015-28
pubmed: 22385965
Nature. 2011 Sep 18;478(7368):255-9
pubmed: 21927002
Cell Stem Cell. 2019 Jan 3;24(1):54-64
pubmed: 30595498
Cancer Cell. 2015 Apr 13;27(4):574-88
pubmed: 25873177
Cell. 2013 Jan 17;152(1-2):25-38
pubmed: 23273993
Stem Cells. 2013 Mar;31(3):602-6
pubmed: 23225641
Nature. 2019 May;569(7754):66-72
pubmed: 31019299
Nature. 2015 Sep 10;525(7568):256-60
pubmed: 26331542
Cell Stem Cell. 2016 Feb 4;18(2):203-13
pubmed: 26831517

Auteurs

Arianna Fumagalli (A)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Koen C Oost (KC)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Molecular Cancer Research, Center for Molecular Medicine, Oncode Insitute, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands.

Lennart Kester (L)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Jessica Morgner (J)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Laura Bornes (L)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Lotte Bruens (L)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands; Molecular Cancer Research, Center for Molecular Medicine, Oncode Insitute, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands.

Lisa Spaargaren (L)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Maria Azkanaz (M)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Tim Schelfhorst (T)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Evelyne Beerling (E)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Maria C Heinz (MC)

Molecular Cancer Research, Center for Molecular Medicine, Oncode Insitute, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands.

Daniel Postrach (D)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Danielle Seinstra (D)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Anieta M Sieuwerts (AM)

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, the Netherlands.

John W M Martens (JWM)

Department of Medical Oncology and Cancer Genomics Netherlands, Erasmus MC Cancer Institute, Erasmus University Medical Center, 3015 GD Rotterdam, the Netherlands.

Stefan van der Elst (S)

Hubrecht Institute-KNAW & University Medical Center Utrecht, 3584 CT Utrecht, the Netherlands.

Martijn van Baalen (M)

Flow Cytometry Facility, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Debajit Bhowmick (D)

Flow Cytometry Facility, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Nienke Vrisekoop (N)

Department of Respiratory Medicine, Center of Translational Immunology, University Medical Center Utrecht, 3584 EA Utrecht, the Netherlands.

Saskia I J Ellenbroek (SIJ)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Saskia J E Suijkerbuijk (SJE)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands.

Hugo J Snippert (HJ)

Molecular Cancer Research, Center for Molecular Medicine, Oncode Insitute, University Medical Center Utrecht, 3584 CX Utrecht, the Netherlands.

Jacco van Rheenen (J)

Department of Molecular Pathology, Oncode Institute, Netherlands Cancer Institute, 1066 CX Amsterdam, the Netherlands. Electronic address: j.v.rheenen@nki.nl.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female
Humans United States Aged Cross-Sectional Studies Medicare Part C
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH